Cleared Traditional

NMP22 BLADDERCHEK KIT, NMP22 CONTROL KIT

K021231 · Matritech, Inc. · Immunology
Jul 2002
Decision
103d
Days
Class 2
Risk

About This 510(k) Submission

K021231 is an FDA 510(k) clearance for the NMP22 BLADDERCHEK KIT, NMP22 CONTROL KIT, a System, Test, Tumor Marker, Monitoring, Bladder (Class II — Special Controls, product code MMW), submitted by Matritech, Inc. (Newton, US). The FDA issued a Cleared decision on July 30, 2002, 103 days after receiving the submission on April 18, 2002. This device falls under the Immunology review panel. Regulated under 21 CFR 866.6010.

Submission Details

510(k) Number K021231 FDA.gov
FDA Decision Cleared SESE
Date Received April 18, 2002
Decision Date July 30, 2002
Days to Decision 103 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code MMW — System, Test, Tumor Marker, Monitoring, Bladder
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.6010

Similar Devices — MMW System, Test, Tumor Marker, Monitoring, Bladder

All 8
Bladder EpiCheck DNA extraction kit, NX899090-01C, Bladder EpiCheck test kit, NX899090-02C, Bladder EpiCheck Software, NX899090-03C
K203245 · Nucleix , Ltd. · May 2023
MODIFICATION TO VYSIS UROVYSION BLADDER CANCER RECURRENCE TEST
K033982 · Vysis · Jan 2004
UROVYSION BLADDER CANCER RECURRENCE KIT
K013785 · Vysis · Feb 2002
VYSIS UROVYSION BLADDER CANCER RECURRENCE KIT
K011031 · Vysis · Aug 2001
BTA STAT TEST PRESCRIPTION HOME USE
K974845 · Bard Diagnostic Sciences,Inc. · Dec 1998
BARD BTA TRAK TEST
K971402 · Bard Diagnostic Sciences,Inc. · Apr 1998